Nachrichten zur Precigen Inc. Aktie

Precigen verfügt mit PAPZIMEOS über die erste und einzige FDA-zugelassene Therapie zur Behandlung der rezidivierenden respiratorischen Papillomatose (RRP) bei…

Does Precigen, Inc. (PGEN) have what it takes to be a top stock pick for momentum investors? Lets find out.…

Precigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the…

…

…

Precigen (PGEN) delivered earnings and revenue surprises of 33.33% and 2.86%, respectively, for the quarter ended December 2024. Do the…

Should investors be excited or worried when a stocks 50 -day simple moving average crosses above the 200-day simple moving…

…

…